Evidence map›Paper›PMID 41180711›Full record

ArticleAnnals of medicine and surgery (2012)2025

Demographic and clinical insights into Stage IV breast cancer: a comparative approach to surgical versus non-surgical treatment outcomes.

Mania Beiranvand, Atieh Akbari, Mohamad Esmaeil Akbari

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mania BeiranvandCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Atieh AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohamad Esmaeil AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer is a major global health challenge, with breast cancer remaining a leading cause of mortality. Stage IV breast cancer, marked by metastasis to distant organs, is particularly complex and is often managed as incurable. Effective treatment decisions are guided by the TNM staging system, though more nuanced approaches are essential to improve patient outcomes. Methods: This retrospective observational study evaluates the demographic and clinical factors associated with Stage IV breast cancer, focusing on the impact of surgical intervention on patient outcomes. The study includes 215 Stage IV breast cancer cases, analyzing clinical variables such as age, reproductive history, hormone receptor status, lymph node involvement, and treatment modalities. Patients are categorized based on whether they received surgical or non-surgical interventions. Results: Among the study population, those who underwent surgery showed statistically significant differences in survival rates and quality of life compared to those who opted for non-surgical treatment. The analysis highlights critical factors like hormone receptor status and lymph node involvement that influence treatment outcomes, providing insights into the potential benefits of surgery even in Stage IV cases. Conclusion: This study underscores the role of surgical intervention as part of a tailored approach to managing Stage IV breast cancer. The findings contribute to a better understanding of factors influencing treatment choices and outcomes, supporting more informed decision-making in clinical practice.

Indexed as

breast cancermetastasissurgical interventionsTNM

Identifiers

PMID41180711
PMCPMC12578046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.